Cargando…
COVID-19 antibody donation using immunoadsorption: Report of two cases
For more than a year the whole world is suffering from the COVID-19 pandemic with no treatment option in sight. Administration of plasma from convalescent donors containing anti-SARS-CoV-2 antibodies, though promising according to case reports, failed to show a clear benefit in a greater number of t...
Autores principales: | Rothenburg, Jannik, Rink-Baron, Silke, Mueller, Lisa, Ostermann, Philipp Niklas, Fischer, Johannes, Stegbauer, Johannes, Moldenhauer, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205282/ https://www.ncbi.nlm.nih.gov/pubmed/34147358 http://dx.doi.org/10.1016/j.transci.2021.103193 |
Ejemplares similares
-
Targeting IgE Antibodies by Immunoadsorption in Atopic Dermatitis
por: Kasperkiewicz, Michael, et al.
Publicado: (2018) -
Safety and Tolerability of Plasma Exchange and Immunoadsorption in Neuroinflammatory Diseases
por: Dorst, Johannes, et al.
Publicado: (2020) -
Immunoadsorption in dilated cardiomyopathy
por: Wakabayashi, Y, et al.
Publicado: (2009) -
Immunoadsorption Column Reuse
por: Tiwari, Vaibhav, et al.
Publicado: (2021) -
Case report: Immunoadsorption therapy for anti-caspr1 antibody-associated nodopathy
por: Liu, Lili, et al.
Publicado: (2022)